Allogeneic stem cell transplantation and combination antiretroviral therapy: cautions, complications, and considerations

Leuk Lymphoma. 2019 Oct;60(10):2584-2587. doi: 10.1080/10428194.2019.1594221. Epub 2019 Apr 3.

Authors

Rory M Shallis¹, Shana Gleeson², Marwan M Azar², Maricar Malinis², Mina L Xu³, Stuart E Seropian¹, Lohith Gowda¹, Amer M Zeidan^{1

4}

Affiliations

¹ Division of Hematology, Department of Medicine, Yale University School of Medicine , New Haven , CT , USA.
² Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine , New Haven , CT , USA.
³ Department of Pathology, Yale University , New Haven , CT , USA.
⁴ Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University , New Haven , CT , USA.

PMID: 30943051
DOI: 10.1080/10428194.2019.1594221

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antiretroviral Therapy, Highly Active*
Bone Marrow / pathology
CD4 Lymphocyte Count
Female
Graft vs Host Disease / etiology
Graft vs Host Disease / prevention & control
HIV Infections / complications
HIV Infections / diagnosis
HIV Infections / drug therapy*
HIV Infections / immunology
Hematopoietic Stem Cell Transplantation* / adverse effects
Hematopoietic Stem Cell Transplantation* / methods
Humans
Immunocompromised Host*
Lymphoma, Follicular / complications
Lymphoma, Follicular / diagnosis
Lymphoma, Follicular / therapy
Middle Aged
Transplantation, Homologous
Treatment Outcome